Broad, hybrid capture-based next generation sequencing of circulating tumor DNA identified actionable genetic alterations in advanced cancer with treatment resistance.

• DOI: 10.1200/jco.2015.33.15_suppl.e22078
• Publication Date: 2019-04-19T20:41:08Z
• Authors: Xiaochun Zhang; Helei Hou; Lihua Deng; Chuantao Zhang; Xiaofeng Cheng; Yanfang Guan; Xiaomei Xu; Xiaofei Wang; Airong Tan; Congmin Liu; Wenjun Yu; Chun Yan; Chengye Guo; Dong Liu; Xiaonan Yang; Rongjiao Wang; Wenqi Liu; Zhuokun Li; Yi Xin
• Keywords: 03 medical and health sciences; 0302 clinical medicine; 3. Good health

e22078 Background: Circulating tumor DNA (ctDNA) is an optional specimen used to identify potentially targetable genetic alterations in solid tumors, particularly for those that developed treatment...